investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Characterizing MSI2 in leukemia
Michael Kharas
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Michael Kharas
Memorial Sloan Kettering Cancer Center
New York, United States
Related projects
Paul M Thompson
ENIGMA Center for Worldwide Medicine, Imaging & Genomics
Leukaemia
Derrick J. Rossi
Reprogramming committed blood cells to a hematopoietic stem cell fate
Leukaemia
Hematology and hematologic malignancies
Christopher J Ott
Chemical Modulation of Chromatin Signaling in Lymphoid Malignancies
Leukaemia
Takeshi Egawa
GENE REGULATION GOVERNING T LYMPHOCYTE FATE DECISIONS
Leukaemia
Kim O'Neill
Cancer Immunology Research at Brigham Young University
Leukaemia
Marc Nicklaus
In Silico Screening for Cancer Targets
Leukaemia
Pathology
Hematology and hematologic malignancies
Katherine L B Borden
Molecular Mechanisms of eIF4E mediated transformation
Leukaemia
Pathology
Hematology and hematologic malignancies
Amy Paguirigan
Connecting Single Cell Heterogeneity to Clinical Descriptors of Clonal Evolution in Acute Myeloid Leukemia
Leukaemia
Daniel McVicar
Characterization of the Expression and Ligands of KIR3DS2
Leukaemia
Pathology
Hematology and hematologic malignancies